Related Experiment Video
Updated: Aug 12, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Diagnosing lung involvement in inflammatory rheumatic diseases-Where do we currently stand?
Tobias Hoffmann1, Peter Oelzner1, Ulf Teichgräber2
1Department of Internal Medicine III, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Early detection of interstitial lung disease (ILD) in inflammatory rheumatic disease (IRD) is crucial. This review details methods like pulmonary function tests (PFTs) and HRCT for diagnosing and monitoring IRD-ILD.
Area of Science:
- Rheumatology
- Pulmonology
- Radiology
Background:
- Lung involvement, primarily interstitial lung disease (ILD), is a frequent and severe complication in patients with inflammatory rheumatic diseases (IRD).
- IRD-ILD manifestations range from asymptomatic findings to severe respiratory failure, underscoring the need for early detection and monitoring.
Purpose of the Study:
- To provide a comprehensive overview of diagnostic and monitoring methods for ILD in IRD patients.
- To discuss the advantages and disadvantages of each method in routine clinical practice.
Main Methods:
- Review of standard screening and monitoring tools including pulmonary function tests (PFTs) like diffusing capacity of the lungs for carbon monoxide (DLCO) and forced vital capacity (FVC).
- Evaluation of high-resolution computed tomography (HRCT) for its high diagnostic accuracy.
- Discussion of advanced imaging like magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) for morphological and functional assessment.
- Consideration of emerging biomarkers (KL-6, CCL2, MUC5B) for detection and prognosis.
- Inclusion of invasive methods such as bronchoalveolar lavage (BAL) and lung biopsy, noting their current clinical relevance and unclear prognostic impact.
Main Results:
- HRCT is highly accurate for ILD diagnosis in IRD patients.
- PFTs (DLCO, FVC) are standard for screening and monitoring.
- MRI and PET/CT offer combined morphological and functional lung assessment.
- Biomarkers show potential for ILD detection and prognosis.
- Invasive methods like BAL and lung biopsy remain important despite unclear prognostic value.
Conclusions:
- A multimodal approach combining PFTs, HRCT, and potentially advanced imaging and biomarkers is essential for effective ILD management in IRD patients.
- The role of invasive procedures requires further clarification regarding their therapeutic and prognostic significance.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management